Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Botulinum toxin: A review of the mode of action in migraine

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prevention after stroke: A quality assurance study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Does continuous electroencephalography influence therapeutic decisions in neurocritical care?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Transcranial low-frequency pulsating electromagnetic fields (T-PEMF) as post-concussion syndrome treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Response to Letter by Lippi and Mattiuzzi

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Diagnosis and management of migraine in ten steps

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Hypersensitivity to calcitonin gene-related peptide in chronic migraine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Author Response: Clinical Characterization of Delayed Alcohol-Induced Headache: A Study of 1,108 Participants

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer

Botulinum toxin serotype A (BoNT/A) was originally used in neurology for the treatment of dystonia and blepharospasms, but is now clinically used worldwide for the treatment of chronic migraine. Still, the possible mode of action of BoNT/A in migraine is not fully known. However, the mode of action of BoNT/A has been investigated in experimental pain as well as migraine models, which may elucidate the underlying mechanisms in migraine. The aim of this study was to review studies on the possible mode of action of BoNT/A in relation to chronic migraine treatment. Observations suggest that the mode of action of BoNT/A may not be limited to the injection site, but also includes anatomically connected sites due to axonal transport. The mechanisms behind the effect of BoNT/A in chronic migraine may also include modulation of neurotransmitter release, changes in surface expression of receptors and cytokines as well as enhancement of opioidergic transmission. Clinical and experimental studies with botulinum toxin in the last decade have advanced our understanding of headache and other pain states. More research into botulinum toxin as treatment for headache is warranted as it can be an attractive alternative for patients who do not respond positively to other drugs.

OriginalsprogEngelsk
TidsskriftActa Neurologica Scandinavica
Vol/bind137
Udgave nummer5
Sider (fra-til)442-451
Antal sider10
ISSN0001-6314
DOI
StatusUdgivet - 2018

Bibliografisk note

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

ID: 62072958